Sign in
4

Changes in Ownership

KIORA PHARMACEUTICALS INC Filed Acc 0001372514-26-000032

Chief Development Officer gave up 929 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Daniels Eric Joseph · Chief Development Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-04-01 Shares withheld for taxes : show line 1 in the form −929 $1.95 $1,812 31,741 D
Loading xslF345X06/wk-form4_1775162772.xml…